INTRODUCTION
Group A Streptococcus pyogenes (GAS) may cause a variety of acute infections such as pharyngitis, impetigo, erysipelas, septicemia and myositis. Nonsuppurative sequelae following GAS infections, especially rheumatic fever and acute glomerulonephritis, are still highly prevalent in developing countries and GAS-mediated diseases remain a major concern exist. For example, it is extremely difficult to keep an entire set of specific M-typing antisera, which is a limiting factor when determining type distribution [2] . Recently, a new typing system for GAS based on emm encoding of the M protein was developed, and Beall et al. [3, 4] reported that nucleotide sequencing of the hypervariable NH # -terminal portion of the emm gene (emm genotyping) was very useful for surveying and monitoring GAS isolate diversity.
GAS produces a number of streptococcal pyrogenic exotoxins (SPEs) that are classified as superantigens, and a recent study revealed that there are more than 10 superantigens or superantigen-like toxin molecules in GAS [5, 6] . Stevens and colleagues [7] considered that TSLS may be caused by SPE-A (encoded by the speA gene), however, Hsueh et al. [8] reported that the presence of speA did not have an involvement with any particular clinical syndrome found in patients with invasive or noninvasive streptococcal infections. An analysis using the GAS genome database of Oklahoma University revealed the presence of several novel superantigens such as SPE-G and SPE-H [5, 6] . Although correlations between the M type, fibronectin-binding protein [9] , and serum opacity factor [10] have been reported, few studies have described such between emm types and superantigen genes.
The emm genotyping method developed by Beall et al. [3] makes it possible to determine rarely occurring emm genes. Thus, we chose this method to better characterize the relationship between the M (emm) type and superantigen profiles of 316 clinical GAS isolates isolated in Japan during the 5-year period 1994-9 in relation to the clinical status of patients with GAS infections. Herein, we first present these profiles.
MATERIALS AND METHODS

Bacterial isolates
A total of 316 isolates of GAS, isolated during 1994-9 in Japan, were obtained from Tokyo Women's Medical College, Osaka Prefectural Institute of Public Health, and Saga Prefectural Institute of Public Health. Seventeen were from patients with invasive infections, which were TSLS (n l 15) and bacteremia (n l 2), while 299 were from those with noninvasive infections. Invasive isolates were obtained from blood (n l 3) or an unknown location (n l 12). Noninvasive isolates included 216 mucosal and 83 skin isolates, with the mucosal isolates coming from the pharynx (n l 141), tonsils (n l 56), respiratory tract\chest (n l 5), ears (n l 4), nose (n l 4), vagina (n l 3), stool (n l 2), and urethra (n l 1).
DNA isolation
For genotyping, bacterial DNA from GAS was prepared according to Saarela's method [11] with some modifications. Briefly, a few GAS colonies were grown on a Todd Hewitt (Becton Dickinson, Sparks, MD, USA) agar plate containing 5 % sheep blood and 0n2 % yeast extract, and then transferred to 50 µl of TE buffer (pH 8n0) (10 m Tris-HCl, 5 m EDTA). Bacterial cells were harvested by centrifugation (20 800 g, 3 min), and the supernatant was then removed. Micro-tubes containing the bacterial cells were placed in a microwave oven and heated for 5 min at a power setting of 500 W. The pellets were then resuspended in 50 µl of TE buffer, further incubated at 37 mC for 30 min, and centrifuged to remove debris. The supernatant was stored at 4 mC until use as a template for polymerase chain reaction (PCR) analysis.
Genotyping of GAS
Genotyping of the emm gene encoding the M protein was done according to the protocol of the Center for Disease Control and Prevention (CDC, http :\\www. cdc.gov\ncidod\biotech\strep\protocols.html), with minor modifications. Briefly, amplification was performed in a total volume of 50 µl consisting of 1 µl of template solution and 2n5 U of Taq-DNA polymerase (PE Applied Biosystems, Branchburg, NJ, USA), with primer 1 (5h-TATTC\GGCTTAGAAAATTAA-3h) and primer 2 (5h-GCAAGTTCTCAGCTTGTTT-3h) according to the manufacturer's instructions. After an initial heating at 94 mC for 5 min, the PCR mixtures were immediately cycled 30 times with a 15-sec denaturing step at 94 mC, a 30-sec annealing step at 46 mC, and a 75-sec extension step at 72 mC in a PCR2400 thermal cycler (PE applied Biosystems). After the last cycle, the samples were incubated at 72 mC for 7 min and then stored at 4 mC.
The amplified DNA was purified by a Centri-Sep spin column (PE Applied Biosystems). The 5h emm sequence of the PCR product was sequenced using primer 1 with a dye termination mix and analysed using the CDC database (http :\\www.cdc.gov\ ncidod\biotech\strep\strepblast.html). We consider-ed an isolate to be within a given emm type if it had a 95 % identity over the first 160 bases obtained.
Determination of superantigen gene
PCR amplification was performed under optimal conditions in order to detect the superantigen genes with specific primer sets. The primer sets used were as follows : speA-f, 5h-GCTCAACAAGACCCCGATC-C-3h and speA-r, 5h-TGTAGGCTTTGGATACCAT-CG-3h (product size ; 393 bp, [12] ) ; speC-f, 5h-GA-CTCTAAGAAAGACATTTCG-3h and speC-r, 5h-AGTCCCTTCATTTGGTGAGTC-3h (product size ; 540 bp, [12] ) ; speG-f, 5h-CTGGATCCGATGAAAA-TTTAAAAGATTTAA-3h and speG-r, 5h-AAGATT-CGGGGGGAGAATAG-3h (product size ; 665 bp, [6] ) ; speH-f, 5h-TTGGATCCAATTCTTATTATAA-TACAAC-3h and speH-r, 5h-GACTCTAAGAAAG-ACATTTCG-3h (product size ; 632 bp, [6] ) ; mf-f, 5h-GAATCTACTTGGATCAAGACGG-3h and mf-r, 5h-CCATCACGATTTGCTTCTAACC-3h (product size 644 bp, this study result) ; ssa-f, 5h-GGTGTAGA-ATTGAGGTAATTGGGG-3h and ssa-r, 5h-GCTAT-AGCTGAAGAGCTCACTGTC-3h (product size ; 839 bp, this study result).
Statistical analysis
All analyses were performed using Fisher's exact test (two-tailed) with the computer application StatView (version 5.0J, SAS Institute Inc, Cary, NC, USA).
RESULTS AND DISCUSSION
Dominant emm genotypes in GAS isolates obtained from noninvasive infections, 1994-9
Clinical isolates of GAS were obtained from skin and mucosal surfaces of patients with impetigo, pharyngitis, and invasive infections (see Materials and Methods).
The emm genotypes of these clinical isolates were determined by nucleotide sequencing of the 5h emm and the presence of superantigen genes was detected by PCR. Genotype emm12 was found to be the most common (17n4 % of the isolates tested), followed by genotypes emm28 (16n8%), emm1 (13n3 %), and emm4 (11n1 %) (Fig. 1, Table 1 ). Eight strains were not included in the emm genotypes, and were classified as genotypes st1135 (n l 1), st2926 (n l 1), st88-25 (n l 1), stns292 (n l 1), and stcmuk16 (n l 4 : Fig. 1 , Table 1 ) as provisional emm types. The provisional isolates known as ' st ' (sequence type ) have not yet been validated by all of the CDC Streptococcus Laboratoryandreferencelaboratories(http :\\www.cdc.gov\ ncidod\biotech\strep\emmtypes.html). We found that GAS genotypes emm1, emm12 and emm28 showed a consistently high occurrence in the 1990s in Japan, while genotype emm4 increased in the late 1990s. These four emm genotypes have also spread globally and are known to have caused pharyngeal infections in the United States [13] , New Zealand [14] , and Iran [15] . Although genotype emm28 isolates were occasionally reported in Japan in the 1980s [16] , the isolation frequency of this GAS genotype increased during the 5 years examined in the present study.
Occurrence of emm genotype in mucosal and skin infections
Genotype emm28 isolates were most prevalent from mucosal sites (see Materials and Methods) and skin infections. Most of the emm12 isolates were from mucosa (48 of 52, P l 0n0015), whereas 7 of 11 emm58 isolates and 5 of 8 emm89 isolates were from skin infections (P l 0n017 and P l 0n045, respectively : Table 1 ). Furthermore, genotypes emm1, emm2 and emm4 were largely found in mucosal infection sites ( Table 1 ). The prevalence of these GAS emm genotypes in our study was consistent with that for invasive infection and pharyngeal isolates reported in the United States [17] and Canada [18] . Further, Bessen and coworkers reported that M11 and M58, major strains found in skin infections in our study, tended to be tissue-specific. [19] .
Occurrence of emm genotype in invasive infections
Clinical isolates from cases with invasive GAS infection (n l 17) were classified as genotypes emm1 (n l 4), emm3 (n l 5), emm12 (n l 3), emm18 (n l 2), emm28 (n l 1), emm44 (n l 1), and emm77 (n l 1). The results showed that genotype emm1 and emm3 isolates occupied 9 (53 %) out of 17 cases. Major invasive isolates in Canada have been shown to be serotypes M1 and M3, which made up 39 % of that study sample, while M12 and M28 were present in 8n8 % and 5n7 %, respectively [20] . A previous study suggested that the dominance of the strain with serotype T3 in TSLS was correlated with the increase in this serotype among streptococcal infections [1] . As compared to the distribution of emm genotypes in noninvasive infections, the rate of genotype emm3 strains from invasive infections (29 %) was significantly dominant as compared with those from noninvasive infections (2 %, P l 0n0003). However, in other emm isolates from invasive infections, we did not find a significantly dominant emm genotype, thus, all the strains of the emm3 genotype were dominant in invasive infections. This is the first known report to show that genotypes emm44 and emm77 were found in isolates from invasive GAS infections.
Distribution of superantigens and correlation with clinical status
All isolates possessed the mf gene regardless of emm genotype or source (Fig. 3) , therefore, MF may not be a major virulence factor specific for TSLS or other invasive diseases. MF was previously recognized as a superantigen [21] , however, a recent study reported it as a DNase of GAS, and not a mitogen, that stimulates lymphoid cells non-specifically [22] . Moreover, Gerlach et al. [23] showed that MF is not a superantigen.
The speC and speG genes were seen in more than 70 % of the isolates, whereas the ssa genes were present in less than 40 % (Figs 2, 3 , Table 2 ). Although no correlation between superantigens and isolation sites was found, more of those from the skin possessed the speG and speH genes than from mucosal sites (Fig. 2) . It was also noted that isolates from both the skin and mucosa harboured similar amounts of speG (86n7 % and 78n2 %, respectively) and speH (43n3% and 39n8 %, respectively).
Although the number of invasive isolates was small, a few interesting superantigen profiles were found in our comparison of invasive and non-invasive isolates. GAS isolates from invasive infections possessed the ssa gene at a significantly higher frequency (76 %) emm and superantigen of S. pyogenes in Japan Prevalence of superantigen genes among GAS isolates from mucosal and skin infections. Mucosal isolates (n l 216) from the pharynx (n l 141), tonsils (n l 56), respiratory tract\chest (n l 5), ears (n l 4), nose (n l 4), vagina (n l 3), stool (n l 2), and urethra (n l 1), as well as skin isolates (n l 83) were analysed. No significant differences were observed using Fisher's exact test. Fig. 3 . Prevalence of superantigen genes among GAS isolates from invasive (n l 17) and non-invasive (n l 299) infections. * Fisher's exact text. P 0n01 and ** P 0n001.
than those from non-invasive patients (37 %, P 0n01, Fig. 3 ). In addition, the occurrence of the speA gene in invasive isolates was 88 %, while that in noninvasive isolates was 65n5%, (P l 0n064) (Fig. 3) . Since SPE-A and SSA are frequently found among various streptococcal superantigens, as has been revealed by amino acid sequencing [5] , it is possible that these exotoxins are involved in the induction of toxic shock. However, our Western blot analysis showed that 47 % of the invasive isolates expressed SPE-A, despite the finding that 88 % possessed the speA gene. Nakashima et al. [24] reported that only 43 % of the invasive isolates found produced SPE-A and 31 % did not contain the speA gene. Therefore, when considering the amounts of toxins studied, there is a little evidence to establish whether SPE-A is closely connected with TSLS or invasive infection. Moreover, Hauser et al. [25] described other factors that are also likely to be important. Since not all of the strains from TSLS patients were found to contain the speA gene, further study by analysing more invasive isolates is required.
More recently, the complete genome sequence of a GAS M1 strain, SF370 (ATCC 700294), was * ** * **** * Fisher's P < 0·05, ** P < 0·01, *** P < 0·001, **** P < 0·0001.
† Small number of emm isolates (n < 5) were combined as 'Others'.
determined [5] , and complete or partial sequences of four other bacteriophage genomes are known. In that study, the speA\C\H\I genes were shown to be associated with a phage gene [5] , whereas the streptococcal mitogenic exotoxin Z, speG [6] , and mf [21] appear to be chromosomally encoded. Since most isolates in our study harboured speG and all had mf, it was considered that SPE-G may not be a major virulence factor specific for invasive infection and chromosomally encoded superantigens might display less virulence.
Correlation of superantigen genes with emm genotypes
When the correlations between the emm genotype and superantigen profiles were analysed (Table 2) , 41 of 42 genotype emm1 isolates were found to possess the speA gene, and all of the genotype emm3 isolates (n l 11) had the speA and ssa genes. The profiles of speA and speC genotypes in emm1 isolates were speA (k) speC (j) (n l 1), speA (j) speC (k) (n l 22 with 3 invasive isolates) and speA (j) speC (j) (n l 19 with 1 invasive isolates), while those in emm3 (n l 11) were speA (j) speC (k) (n l 8 with 5 invasive isolates) and speA (j) speC (j) (n l 3). Murase et al. [26] reported a comparison of superantigen profiles by PCR analysis in serotype M1\T1 and M3\T3 isolates during the periods 1981-8 and 1989-97. They showed that the spe genotype profiles in M1T1 isolates changed from speA (k) speC (k)\speA (k) speC (j) in the earlier period to speA (j) speC (k)\speA (j) speC (j) in the later period. In contrast, the profiles of almost all M3T3 isolates were speA (j) speC (j) during both periods and did not change. Our results were identical to their profiles in the later period, showing that genotype emm1 strains with the speA gene have apparently increased in Japan as a result of the speAassociated phage gene. Compared with the superantigen profiles of other emm isolates, isolates of genotype emm2 (9 of 12) and emm4 (29 of 35) possessed the ssa gene at ratios of 75 % and 83 %, respectively (P 0n01). Among a total of 55 genotype emm12 isolates, 50, 51, and 45 isolates possessed speC (P 0n01), speG (P 0n01), and speH (P 0n0001), respectively. Further, 15 of 17 genotype emm13 isolates harboured speH (P 0n01). It was noteworthy that a significant number of genotype emm4 isolates did not have the speG gene (Table 2) , whereas many others possessed it. These results suggest that the distribution of emm genotypes is related to superantigens, and are the first to show the profiles of speG and speH. However, speH has not been characterized precisely, and more information is needed to clarify the association between the clinical features and pathogenic roles of SPE-H.
Ferretti et al. [5] also showed that the location of virulence-associated genes near the integration site emm and superantigen of S. pyogenes in Japan of each complete phage and the ubiquitous presence of phages in GAS assure the possibility of horizontal gene transfers by these virulence determinants, which would play an important role in increasing the pathogenic potential of the organism as well as in its overall evolution. However, Sriskandan et al. [22] considered that the chromosomally encoded virulence factors must account for the lethality of invasive organisms. Therefore, it seems important to examine the role of phage-associated genes or chromosomally encoded genes as possible virulence factors in invasive GAS infections.
